Brainstorm Cell Therapeutics | BCLI - Debt

Stock Price
0.92
Daily Change
0.03 3.92%
Monthly
33.08%
Yearly
-33.94%
Q1 Forecast
0.82

Brainstorm Cell Therapeutics reported $1.2M in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Alterity Therapeutics Limited AUD 210.39K 120.67K Jun/2023
Biogen USD 6.29B 1.7M Dec/2025
Brainstorm Cell Therapeutics USD 1.2M 1.2M Mar/2025
Cipla INR 4.38B 231.9M Mar/2025
Clal Biotechnology ILS 35.76M 28.27M Dec/2023
Compugen USD 2.95M 24K Sep/2025
CSL USD 11.96B 219M Dec/2024
Cytokinetics USD 1.2B 338.79M Sep/2025
Gilead Sciences USD 24.94B 5M Sep/2025
Grifols EUR 9.23B 626.05M Dec/2024
Halozyme Therapeutics USD 1.51B 1.66M Sep/2025
Mesoblast USD 128.16M 9.23M Jun/2025